Dr. Hood is the CEO of Phenome Health, a non-profit organization planning to develop a project called Beyond the Human Genome (BHG), based on the science of wellness, which will sequence the genes and generate the longitudinal phenomes of one million people over 10 years. Phenome Health is well positioned to deliver a new paradigm in healthcare based on prediction, prevention, personalization, and participation, and is intended to address several healthcare challenges: significantly improve health outcomes; facilitate brain health; increase cost effectiveness; reduce the chronic disease burden; promote healthy aging; and enhance U.S. leadership in medical innovation. He has co-founded 17 biotech companies including Amgen, Applied Biosystems, Rosetta and Arivale. His many national and international awards include the Lasker Prize, the Kyoto Prize, and the National Medal of Science. Currently he is Chief Science Officer of Providence St. Joseph, and Co-Founder and Professor at the Institute of Systems Biology in Seattle. 

© 2021 BioFutureTM. All Rights Reserved

Produced by